Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-02-28
1991-06-04
Brust, Joseph Paul
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514341, 514397, 514400, 546256, 546278, 548336, 548342, A61K 3144, A61K 31415, A61K 3138, C07D40313
Patent
active
050214314
ABSTRACT:
New imidazolylalkyl-guanidine derivatives are described, which by virtue of their agonistic action on histamine-H.sub.2 receptors and in part also due to their additional H.sub.1 -antagonistic receptor activity can be used in the treatment of cardiac diseases, certain forms of hypertension and diseases of arterial occlusion.
These imidazolylalkyl-guanidine derivatives correspond to the general formula I: ##STR1##
REFERENCES:
patent: Re29761 (1978-09-01), Durant et al.
patent: 3736331 (1973-05-01), Black et al.
patent: 4048319 (1977-09-01), Black et al.
patent: 4098898 (1978-07-01), Durant et al.
patent: 4109003 (1978-08-01), Durant et al.
patent: 4912119 (1990-03-01), Buschauer et al.
Ahrens Kurt H.
Baumann Gert
Buschauer Armin
Elz Sigurd
Schickaneder Helmut
Brust Joseph Paul
Heumann Pharma GmbH & Co.
LandOfFree
Imidazolyl alkyl guanidine derivatives, processes for their prep does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazolyl alkyl guanidine derivatives, processes for their prep, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazolyl alkyl guanidine derivatives, processes for their prep will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1026594